Women’s Health: Healthcare’s Largest Underserved Market and Biggest Growth Opportunity

About this session

Why now? The time is now. Must be positioned as a systemic market failure and the biggest commercial opportunity of the next decade.This is not about representation/feminism. It’s about missed revenue, broken clinical models, and outdated investment theses. This is not niche, its macro Macro question: How much value has the industry left on the table by designing healthcare around the wrong default patient?

Speakers

• 

  Anastasiya Markvarde

  Head · Eir Accelerator

  Moderator

• 

  Dana Burduja

  Head of Life Sciences and Health · European Investment Bank (EIB)

  Panelist

• 

  Jessica Federer

  Managing Director · Women's Health Fund

  Panelist

• 

  Kelle Moley

  VP, Women's Health and Early Clinical Development · Eli Lilly and Company

  Panelist

• 

  Melindah Sharma

  Co-Chair, Women’s Health Catalyst – Cardiovascular Health, Wyss Institute · Harvard University

  Panelist

• 

  Marie Teil

  Global Head of Special Patient Populations · UCB

  Panelist